Dr. Becker's research studies include the mechanism of cell adhesion-mediated chemotherapy resistance in AML, hematopoietic stem cell gene therapy for an inherited disorder of DNA repair, and precision therapy for AML and multiple myeloma, based on high-throughput drug sensitivity testing.
Get the latest thought leadership on AML delivered straight to your inbox.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.
Thanks to our HealthTree Community for AML Sponsors:
%20-%20smaller%20jpg_5093a115-769d-4cb8-99c4-e07244874f4d.jpg?alt=media){kind=logo}
Follow Us
Terms of Use and Privacy Policy Newsroom About Donations Find an AML Specialist Newsletter Learn Connect
Copyright © 2022 HealthTree Foundation. All Rights Reserved.
The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811
